R-Tech Ueno, Japanese pharmaceutical company, has filed for and received FDA IND approval to begin Phase I and II clinical trials of its severe dry eye treatment, RU -101. Ophthalmic solution RU-101 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results